References
Wong T, Girgis CM, Ngu MC, Chen RC, Emmett L, Archer KA, et al. Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B. J Clin Endocrinol Metab. 2010;95:479–80.
Girgis CM, Wong T, Ngu MC, Emmett L, Archer KA, Chen RC, et al. Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol. 2011;45:468–73.
Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, Currie G, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int. 2004;66:1153–8.
Tanaka M, Setoguchi T, Ishidou Y, Arishima Y, Hirotsu M, Saitoh Y, et al. Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report. Diagn Pathol. 2012;7:108.
Kim DH, Sung DH, Min YK. Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review. J Bone Miner Metab. 2013;31:240–6.
Kim DH, Lee SW, Kweon YO, Lee J, Ahn BC. Bone scintigraphic findings of hypophosphatemic osteomalacia associated with adefovir therapy. Clin Nucl Med. 2013;38:278–80.
Seo HJ, Choi YJ, Kim HJ, Jeong YH, Cho A, Lee JH, et al. Using 18F-FDG PET/CT to detect an occult mesenchymal tumor causing oncogenic osteomalacia. Nucl Med Mol Imaging. 2011;45:233–7.
Conflict of Interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, S.H., Won, K.S., Song, BI. et al. Low-Dose Adefovir-Induced Hypophosphatemic Osteomalacia on Whole-Body Bone Scintigraphy. Nucl Med Mol Imaging 47, 294–296 (2013). https://doi.org/10.1007/s13139-013-0223-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-013-0223-7